NSPR
InspireMD, Inc.
NASDAQ · ILHealthcareMedical - Devices
$0.70+0.33%
Price as of Jul 20, 2026
NSPR financials
InspireMD, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M |
| Cost of revenue | $6.3M | $5.5M | $4.4M | $4.1M |
| Gross profit | $2.6M | $1.5M | $1.8M | $1.1M |
| Operating expenses | $51.8M | $35.0M | $22.9M | $19.8M |
| Operating income | -$49.1M | -$33.5M | -$21.1M | -$18.7M |
| Net income | -$48.8M | -$32.0M | -$19.9M | -$18.5M |
| EBITDA | -$48.2M | -$31.7M | -$19.6M | -$18.3M |
| Basic EPS | $-0.76 | $-0.76 | $-0.82 | $-2.35 |
| Diluted EPS | $-0.76 | $-0.76 | $-0.82 | $-2.35 |
| Balance sheet | ||||
| Cash & equivalents | $8.9M | $18.9M | $9.6M | $4.6M |
| Total assets | $69.4M | $46.8M | $47.6M | $24.7M |
| Total liabilities | $14.2M | $10.7M | $8.1M | $7.3M |
| Stockholders’ equity | $55.2M | $36.1M | $39.5M | $17.4M |
| Total debt | $3.3M | $2.3M | $1.6M | $1.6M |
| Net debt | -$5.6M | -$16.6M | -$8.0M | -$3.0M |
| Cash flow | ||||
| Operating cash flow | -$35.1M | -$21.9M | -$16.4M | -$15.5M |
| Capital expenditure | -$1.7M | -$1.4M | -$381.0K | -$473.0K |
| Free cash flow | -$36.8M | -$23.3M | -$16.8M | -$16.0M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |